Astrana Health, Inc.
ASTH
$24.19
-$0.08-0.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -32.38% | 490.49% | |||
| Total Other Revenue | -0.06% | 44.25% | |||
| Total Revenue | -0.58% | 46.00% | |||
| Cost of Revenue | -0.39% | 48.89% | |||
| Gross Profit | -2.21% | 24.65% | |||
| SG&A Expenses | 17.20% | 2.69% | |||
| Depreciation & Amortization | 5.17% | 125.88% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.69% | 46.03% | |||
| Operating Income | -40.38% | 45.08% | |||
| Income Before Tax | 32.36% | -66.29% | |||
| Income Tax Expenses | -79.45% | -30.49% | |||
| Earnings from Continuing Operations | 509.29% | -89.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 20.03% | 11.22% | |||
| Net Income | 1,508.31% | -96.04% | |||
| EBIT | -40.38% | 45.08% | |||
| EBITDA | -24.63% | 65.57% | |||
| EPS Basic | 1,503.95% | -96.03% | |||
| Normalized Basic EPS | -90.85% | 0.66% | |||
| EPS Diluted | 1,503.95% | -96.00% | |||
| Normalized Diluted EPS | -90.84% | 0.66% | |||
| Average Basic Shares Outstanding | 0.03% | 0.06% | |||
| Average Diluted Shares Outstanding | 0.11% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||